HIV 1 News and Research

RSS

Researchers develop prototype COVID-19 vaccine using DNA vaccine platform

It is necessary to develop additional COVID-19 vaccines, as different vaccine approaches have their advantages and disadvantages and may work synergistically.

4 Feb 2021

Study gives new clues to how muscle wasting occurs on a cellular level

Muscle wasting, or the loss of muscle tissue, is a common problem for people with cancer, but the precise mechanisms have long eluded doctors and scientists. Now, a new study led by Penn State researchers gives new clues to how muscle wasting happens on a cellular level.

3 Feb 2021

Phase 1 clinical trial of novel HIV vaccine approach shows promising results

A phase 1 clinical trial testing a novel vaccine approach to prevent HIV has produced promising results, IAVI and Scripps Research announced today.

3 Feb 2021

Experimental intranasal influenza vaccine produces durable immune response

An experimental single-dose, intranasal influenza vaccine was safe and produced a durable immune response when tested in a Phase 1 study published in the Journal of Clinical Investigation.

3 Feb 2021

Long COVID-19 symptoms not associated with reduced cell-mediated immunity, finds study

A new preprint examines Long COVID-19, aiming to identify the underlying immunologic status in such patients.

3 Feb 2021

Researchers report trial results of rectal microbicides at HIV R4P Virtual Conference

Researchers seeking to develop on-demand and behaviorally congruent HIV prevention options for people who practice anal sex are reporting the results of three early phase clinical trials of rectal microbicides at this week's HIV Research for Prevention (HIV R4P) Virtual Conference.

3 Feb 2021

Fear-based messaging fails to reduce risky driving behaviour, indicates study

New drivers between the ages of 15 and 25 account for nearly half of the more than one million road deaths that occur worldwide each year, according to the World Health Organization. Educational programs often use fear-based messaging and films of crash scenes to reduce risky driving behavior among young people.

3 Feb 2021

Johnson & Johnson SARS-CoV-2 vaccine shows promise in clinical trials

A new study shows that a single immunization with a low dose of the Ad26.COV2.S vaccine – also known as the ‘Johnson & Johnson vaccine’ – effectively protected against SARS-CoV-2 challenge in rhesus macaques.

2 Feb 2021

WHO recommends dapivirine vaginal ring as additional HIV prevention choice for at-risk women

WHO today recommended that the dapivirine vaginal ring (DPV-VR) may be offered as an additional prevention choice for women at substantial risk of HIV infection as part of combination prevention approaches.

1 Feb 2021

Increased access to testing, treatment has reduced hepatitis C in low- and middle-income countries

Many low- and middle-income countries have reduced suffering from hepatitis C, thanks to increased access to testing and treatment.

1 Feb 2021

When your chance for a covid shot comes, don’t worry about the numbers

When getting vaccinated against covid-19, there's no sense being picky. You should take the first authorized vaccine that's offered, experts say.

1 Feb 2021

Use of antiviral and antiretroviral medication could have detrimental impact on crops

The increased global use of antiviral and antiretroviral medication could have a detrimental impact on crops and potentially heighten resistance to their effects, new research has suggested.

29 Jan 2021

Viral ExoN regulates the rate of recombination in SARS-CoV-2

Researchers at Vanderbilt University Medical Center (VUMC) and the University of Texas Medical Branch (UTMB) at Galveston have discovered what may be the Achilles' heel of the coronavirus, a finding that may help close the door on COVID-19 and possibly head off future pandemics.

28 Jan 2021

R&D lacking on emerging infectious diseases, report finds

As research into COVID-19 swells, R&D on other infectious diseases is seriously lacking, report finds.

27 Jan 2021

Remdesivir, given to half of hospitalized covid patients in U.S., is big win for Gilead — boosted by taxpayers

It was the end of April — just as the U.S. confirmed its millionth covid-19 case and 50,000 deaths — when White House adviser Dr. Anthony Fauci announced "highly significant" news about a drug called remdesivir.

27 Jan 2021

Medicaid expansion helps detect more numbers of undiagnosed HIV infections

The Medicaid expansion facilitated by the Affordable Care Act led to increases in the identification of undiagnosed HIV infections and in the use of HIV prevention services such as preexposure prophylaxis drugs, says new research co-written by a team of University of Illinois Urbana-Champaign experts who study the intersection of health care and public policy.

27 Jan 2021

Amid covid health worker shortage, foreign-trained professionals sit on sidelines

As hospitals nationwide struggle with the latest covid-19 surge, it's not so much beds or ventilators in short supply. It's the people to care for the sick.

25 Jan 2021

Socioeconomic conditions linked to high viral load despite treatment for HIV patients in Ethiopia

For those who are diagnosed and have begun treatment for HIV, it is standard practice to regularly monitor viral load in the blood to assess response to treatment.

25 Jan 2021

Study shows disproportionate impact of COVID-19 on Black and Asian populations

Patients of Asian and black backgrounds suffered disproportionate rates of premature death from COVID-19, according to a study of 1,737 patients by Queen Mary University of London and Barts Health NHS Trust.

22 Jan 2021

FDA approves first injectable, complete regimen for HIV-1 infection in adults

The U.S. Food and Drug Administration today approved Cabenuva (cabotegravir and rilpivirine, injectable formulation) as a complete regimen for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in adults to replace a current antiretroviral regimen in those who are virologically suppressed on a stable antiretroviral regimen with no history of treatment failure and with no known or suspected resistance to either cabotegravir or rilpivirine.

21 Jan 2021

HIV 1 News and Research

Researchers develop prototype COVID-19 vaccine using DNA vaccine platform

Study gives new clues to how muscle wasting occurs on a cellular level

Phase 1 clinical trial of novel HIV vaccine approach shows promising results

Experimental intranasal influenza vaccine produces durable immune response

Long COVID-19 symptoms not associated with reduced cell-mediated immunity, finds study

Researchers report trial results of rectal microbicides at HIV R4P Virtual Conference

Fear-based messaging fails to reduce risky driving behaviour, indicates study

Johnson & Johnson SARS-CoV-2 vaccine shows promise in clinical trials

WHO recommends dapivirine vaginal ring as additional HIV prevention choice for at-risk women

Increased access to testing, treatment has reduced hepatitis C in low- and middle-income countries

When your chance for a covid shot comes, don’t worry about the numbers

Use of antiviral and antiretroviral medication could have detrimental impact on crops

Viral ExoN regulates the rate of recombination in SARS-CoV-2

R&D lacking on emerging infectious diseases, report finds

Remdesivir, given to half of hospitalized covid patients in U.S., is big win for Gilead — boosted by taxpayers

Medicaid expansion helps detect more numbers of undiagnosed HIV infections

Amid covid health worker shortage, foreign-trained professionals sit on sidelines

Socioeconomic conditions linked to high viral load despite treatment for HIV patients in Ethiopia

Study shows disproportionate impact of COVID-19 on Black and Asian populations

FDA approves first injectable, complete regimen for HIV-1 infection in adults

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News